Antibodies
Login
Search   
PE/Cy7 anti-human CD206 (MMR) Antibody
PE/Cy7 anti-human CD206 (MMR) Antibody
321123 25 tests ¥25,000     
321124 100 tests ¥54,000     

Product Details

Clone: 15-2
Isotype: Mouse IgG1, κ
Isotype Control:PE/Cy7 Mouse IgG1, κ Isotype Ctrl
Reactivity: Human
Immunogen: Purified human mannose receptor
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and 0.2% (w/v) BSA (origin USA).
Preparation: The antibody was purified by affinity chromatography and conjugated with PE/Cy7 under optimal conditions. The solution is free of unconjugated PE/Cy7 and unconjugated antibody.
Storage & Handling: The antibody solution should be stored undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
Application:

FC - Quality tested

Recommended Usage:

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. Test size products are transitioning from 20 µl to 5 µl per test. Please check your vial or your CoA to find the suggested use of this reagent per million cells in 100 µl staining volume or per 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application. Read more at www.biolegend.com/testsize regarding the test size change.

COA:
Enter Lot#:   
Application
Notes:

The 15-2 antibody blocks the interaction of MMR with its ligand, and inhibits mannose receptor-mediated degradation of t-PA by macrophages. Additional reported applications of this antibody (for the relevant formats) include: Western blotting1, blocking of ligand binding1,2, and immunohistochemical staining of acetone-fixed frozen tissue sections1. The LEAF™ purified antibody (Endotoxin <0.1 EU/μg, Azide-Free, 0.2 μm sterile-filtered) is recommended for functional assays (Cat. No. 321112).

  Cy3, Cy5, Cy5.5 and Cy7 are subject to proprietary rights of GE Healthcare Bio-Sciences Corp. and Carnegie Mellon University and made and sold under license from GE Healthcare Bio-Sciences Corp. Sale of this product is licensed for research use only.
Application
References:

1. Noorman F, et al. 1997. J. Leukocyte Biol. 61:63. (WB IHC Block)
2. Barrett-Bergshoeff M, et al. 1997. Thromb Haemost. 77:718. (Block)

GM-CSF-stimulated (3 days) human peripheral
GM-CSF-stimulated (3 days) human peripheral blood monocytes were stained with CD206 (clone 15-2) PE/Cy7 (filled histogram) or mouse IgG1, κ PE/Cy7 isotype control (open histogram).


Compare all formats

See PE/Cy7 spectral data



Description:

Macrophage mannose receptor (MMR) is a 162-175 kD type I membrane protein also known as CD206, MRC1, or mannose receptor (MR). It is a pattern recognition receptor (PRR) that belongs to C-type lectin superfamily. MMR is expressed on macrophages, dendritic cells, and hepatic or lymphatic endothelial cells, but not on monocytes. MMR recognizes a range of microbial carbohydrates bearing mannose, fucose, or N-acetyl glucosamine. MMR mediates endocytosis and phagocytosis, induces activation of macrophages and antigen presentation, plays an important role in host defense, and provides a link between innate and adaptive immunity.

Other Names: MMR (macrophage mannose receptor), MR (mannose receptor), CD206, MRC1
Structure: Type I membrane protein, Pattern Recognition Receptor (PRR) family, C-type lectin superfamily, 162-175 kD.
Distribution: Macrophages, dendritic cells, hepatic and lymphatic endothelial cells
Function: Pathogen binding, facilitate phagocytosis and endocytosis, macrophage activation and antigen presentation
Ligand Receptor: Mannose, fucose, N-acetyl glucosamine
Antigen
References:

1. Mason D, et al. Eds. 2002. Leukocyte Typing VII. Oxford University Press. p303
2. Wileman TE, et al. 1986. P. Natl. Acad. Sci. USA 83:2501.
3. Apostolopoulos V and I.F. McKenzie, 2001. Curr. Mol. Med. 1:469.
4. Le Cabec V, et al. 2005. J. Leukocyte Biol. 77:934.
5. Barrett-Bergshoeff M, et al. 1997. Thromb. Haemostatis 77:718.

GeneID: 4360
Latest Publications: View the latest CD206 articles on HighwirePress.com
UniProt: View information about CD206 on UniProt.org
Keywords: PE/Cy7 anti-human CD206 (MMR), 15-2, PE/Cy7, MMR (macrophage mannose receptor), MR (mannose receptor), CD206, MRC1, Human, Immunology, Antibodies
Related Products

DescriptionCloneApplications
PE/Cy7 Mouse IgG1, κ Isotype CtrlMOPC-21FC, ICFC
Cell Staining BufferFC, ICC, ICFC
RBC Lysis Buffer (10X)FC, ICFC
Human TruStain FcX™ (Fc Receptor Blocking Solution)FC, ICC, ICFC

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/terms). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.
x
Compare Data Across All Formats
This data display is provided for general comparisons between formats. Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors. If you need assistance with selecting the best format contact our expert technical support team.

  • Purified anti-human CD206 (MMR)
    GM-CSF-stimulated (day-3) human monocytes stained

    GM-CSF-stimulated (day-3) human monocytes stained with purified 15-2, followed by anti-mouse IgG FITC

  • FITC anti-human CD206 (MMR)
    GM-CSF stimulated (day3) human peripheral

    GM-CSF stimulated (day3) human peripheral blood monocytes stained with 15-2 FITC

  • PE anti-human CD206 (MMR)
    GM-CSF-stimulated (day-3) human monocytes stained

    GM-CSF-stimulated (day-3) human monocytes stained with 15-2 PE

  • PE/Cy5 anti-human CD206 (MMR)
    GM-CSF-stimulated human peripheral blood monocytes

    GM-CSF-stimulated human peripheral blood monocytes (day-3) stained with 15-2 PE/Cy5

  • APC anti-human CD206 (MMR)
    GM-CSF- stimulated (day-3) human monocytes

    GM-CSF- stimulated (day-3) human monocytes stained with 15-2 APC

  • Alexa Fluor® 488 anti-human CD206 (MMR)
    GM-CSF-stimulated (day-3) human monocytes stained

    GM-CSF-stimulated (day-3) human monocytes stained with 15-2 Alexa Fluor® 488

  • Alexa Fluor® 647 anti-human CD206 (MMR)
    GM-CSF-stimulated (day-3) human monocytes stained

    GM-CSF-stimulated (day-3) human monocytes stained with 15-2 Alexa Fluor® 647

  • Biotin anti-human CD206 (MMR)
    GM-CSF-stimulated human peripheral blood monocytes

    GM-CSF-stimulated human peripheral blood monocytes (day-3) stained with biotinylated 15-2, followed by Sav-PE

  • APC/Cy7 anti-human CD206 (MMR)
    GM-CSF- stimulated (day-3) human monocytes

    GM-CSF- stimulated (day-3) human monocytes stained with 15-2 APC/Cy7

  • PerCP/Cy5.5 anti-human CD206 (MMR)
    GM-CSF-stimulated (3 days) human peripheral

    GM-CSF-stimulated (3 days) human peripheral blood monocytes were stained with CD206 (clone 15-2) PerCP/Cy5.5 (filled histogram) or mouse IgG1, κ PerCP/Cy5.5 isotype control (open histogram).

  • PE/Cy7 anti-human CD206 (MMR)
    GM-CSF-stimulated (3 days) human peripheral

    GM-CSF-stimulated (3 days) human peripheral blood monocytes were stained with CD206 (clone 15-2) PE/Cy7 (filled histogram) or mouse IgG1, κ PE/Cy7 isotype control (open histogram).

x
Copyright © 2012 BioLegend, Inc. All rights reserved.